Original Article Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib

Authors
Publication date
1 January 2015
Publisher

Abstract

Abstract: Purpose: This study evaluated the efficacy and adverse effects of Imatinib therapy to advanced Dermatofibrosarcoma protuberan (DFSP) and Sunitinib therapy to advanced Dermatofibrosarcoma protuberan (DFSP) after Imatinib resistance. Methods: We analyzed the efficacy, adverse effects and survival of 95 patients with locally advanced or metastatic DFS

    Similar works

    Full text

    thumbnail-image

    Available Versions

    CiteSeerX

    redirect
    oaioai:CiteSeerX.psu:10.1.1.1050....
    Last time updated on 07/12/2020